國立高雄大學圖資館 |

Language: English

Back

Precision oncology and cancer biomarkersissues at stake and matters of concern /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Precision oncology and cancer biomarkersedited by Anne Bremer, Roger Strand.
Reminder of title:	issues at stake and matters of concern /
other author:	Bremer, Anne.
Published:	Cham :Springer International Publishing :2022.
Description:	xiv, 281 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Oncology.
Online resource:	https://doi.org/10.1007/978-3-030-92612-0
ISBN:	9783030926120$q(electronic bk.)

Precision oncology and cancer biomarkersissues at stake and matters of concern /
Precision oncology and cancer biomarkersissues at stake and matters of concern /[electronic resource] :edited by Anne Bremer, Roger Strand. - Cham :Springer International Publishing :2022. - xiv, 281 p. :ill., digital ;24 cm. - Human perspectives in health sciences and technology,v. 52661-8923 ;. - Human perspectives in health sciences and technology ;v.2..

Introduction (Anne Bremer and Roger Strand) -- Chapter 1. Precision oncology in the news (Mille Stenmarck and Irmelin Nilsen) -- Chapter 2. Cancer biomarkers from a patient's perspective (Karen Gissum) -- Chapter 3. Breast cancer: reconstruction of trouble (Hanna Dillekas) -- Chapter 4. HER2: an apparently 'simple' biomarkers revealing the complexities and uncertainties of precision oncology (Elisabeth Wik, Anne Bremer and Lars A. Akslen) -- Chapter 5. Integrating genomic and non-genomic factors in shaping the personal fingerprint in personalised cancer treatments (Mariano Bizzari and Andrea Pensotti) -- Chapter 6. Systems medicine and perspectives on precision oncology (Rune Kleppe, Inge Jonassen and Roger Strand) -- Chapter 7. Precision oncology: the challenges related to publishing (Maria Lie Lotsberg) -- Chapter 8. Filled with Desire, Perceive Molecules (Caroline Engen and Roger Strand) -- Chapter 9. Precision health and ethical ambiguity: How much cancer can we afford to prevent? (Leonard Fleck) -- Chapter 10. New cancer drugs and the public controversy: how can biomarkers contribute? (Eirik Tranvag and Roger Strand) -- Chapter 11. Assessing the cost-effectiveness of targeted therapies and checkpoint inhibitors (John Cairns) -- Chapter 12. Real-world data in Health Technology Assessment of targeted cancer therapy (Jiyeon Kang) -- Chapter 13. Negotiating safety and resources in a first in human cancer trial in Denmark (Line Hillersdal) -- Conclusion: Precision oncology: Fact or fantasy? (Roger Strand and Anne Bremer)

Open access.

This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients' experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.

ISBN: 9783030926120$q(electronic bk.)

Standard No.: 10.1007/978-3-030-92612-0doiSubjects--Topical Terms:

195181
Oncology.

LC Class. No.: RC262

Dewey Class. No.: 616.994

Precision oncology and cancer biomarkersissues at stake and matters of concern /
LDR:04069nmm a2200373 a 4500 001 623532
003 DE-He213
005 20220329035514.0
006 m d
007 cr nn 008maaau
008 221209s2022 sz s 0 eng d
020 $a 9783030926120$q(electronic bk.)
020 $a 9783030926113$q(paper)
024 7 $a 10.1007/978-3-030-92612-0 $2 doi
035 $a 978-3-030-92612-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC262
072 7 $a HP $2 bicssc
072 7 $a MBDC $2 bicssc
072 7 $a MED050000 $2 bisacsh
072 7 $a QD $2 thema
072 7 $a MBDC $2 thema
082 0 4 $a 616.994 $2 23
090 $a RC262 $b .P923 2022
245 0 0 $a Precision oncology and cancer biomarkers $h [electronic resource] : $b issues at stake and matters of concern / $c edited by Anne Bremer, Roger Strand.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xiv, 281 p. : $b ill., digital ; $c 24 cm.
490 1 $a Human perspectives in health sciences and technology, $x 2661-8923 ; $v v. 5
505 0 $a Introduction (Anne Bremer and Roger Strand) -- Chapter 1. Precision oncology in the news (Mille Stenmarck and Irmelin Nilsen) -- Chapter 2. Cancer biomarkers from a patient's perspective (Karen Gissum) -- Chapter 3. Breast cancer: reconstruction of trouble (Hanna Dillekas) -- Chapter 4. HER2: an apparently 'simple' biomarkers revealing the complexities and uncertainties of precision oncology (Elisabeth Wik, Anne Bremer and Lars A. Akslen) -- Chapter 5. Integrating genomic and non-genomic factors in shaping the personal fingerprint in personalised cancer treatments (Mariano Bizzari and Andrea Pensotti) -- Chapter 6. Systems medicine and perspectives on precision oncology (Rune Kleppe, Inge Jonassen and Roger Strand) -- Chapter 7. Precision oncology: the challenges related to publishing (Maria Lie Lotsberg) -- Chapter 8. Filled with Desire, Perceive Molecules (Caroline Engen and Roger Strand) -- Chapter 9. Precision health and ethical ambiguity: How much cancer can we afford to prevent? (Leonard Fleck) -- Chapter 10. New cancer drugs and the public controversy: how can biomarkers contribute? (Eirik Tranvag and Roger Strand) -- Chapter 11. Assessing the cost-effectiveness of targeted therapies and checkpoint inhibitors (John Cairns) -- Chapter 12. Real-world data in Health Technology Assessment of targeted cancer therapy (Jiyeon Kang) -- Chapter 13. Negotiating safety and resources in a first in human cancer trial in Denmark (Line Hillersdal) -- Conclusion: Precision oncology: Fact or fantasy? (Roger Strand and Anne Bremer)
506 $a Open access.
520 $a This open access book reflects on matters of social and ethical concern raised in the daily practices of those working in and around precision oncology. Each chapter addresses the experiences, concerns and issues at stake for people who work in settings where precision oncology is practiced, enacted, imagined or discussed. It subsequently discusses and analyses bioethical dilemmas, scientific challenges and economic trade-offs, the need for new policies, further technological innovation, social work, as well as phenomenological research. This volume takes a broad actor-centred perspective as, whenever cancer is present, the range of actors with issues at stake appears almost unlimited. This perspective and approach opens up the possibility for further in-depth and diverse questions, posed by the actors themselves, such as: How are cancer researchers navigating biological uncertainties? How do clinicians and policy-makers address ethical dilemmas around prioritisation of care? What are the patients' experiences with, and hopes for, precision oncology? How do policy-makers and entrepreneurs envisage precision oncology? These questions are of great interest to a broad audience, including cancer researchers, oncologists, policy-makers, medical ethicists and philosophers, social scientists, patients and health economists.
650 0 $a Oncology. $3 195181
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Philosophy of Medicine. $3 275170
650 2 4 $a Bioethics. $3 195040
650 2 4 $a Cancer Biology. $3 920982
650 2 4 $a Public Health. $3 320661
650 2 4 $a Health Economics. $3 522380
700 1 $a Bremer, Anne. $3 925771
700 1 $a Strand, Roger. $3 925772
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Human perspectives in health sciences and technology ; $v v.2. $3 858423
856 4 0 $u https://doi.org/10.1007/978-3-030-92612-0
950 $a Religion and Philosophy (SpringerNature-41175)